Navigation Links
Breast cancer research and inkjet tissue printing get NSF boost
Date:11/5/2007

CLEMSON The National Science Foundation (NSF) has awarded $2 million to the Center for Biological Interfaces of Engineering (CBIOE) at Clemson University for the development of engineered tissues that will be used to study the causes, progression and treatment of breast cancer.

The tissue engineering technology, which was pioneered at Clemson, is based on inkjet printing and will allow the creation of identical tissue samples that can be used to build cause and effect models.

We will expose these identical tissue models to different environmental conditions to better understand what causes and then stimulates the development of breast cancer. Our research team includes breast cancer surgeons, engineers and scientists the breadth of expertise is tremendous and absolutely crucial for this very complex problem, said CBIOE director Karen Burg, who will lead the multi-disciplinary research team.

Other collaborating investigators include Steve Ellis and Susan Duckett in animal and veterinary sciences, Thomas Boland in bioengineering, Amy Moran in biological sciences, Jason McNeill in chemistry and Rick Groff and Timothy Burg in electrical and computer engineering. The initiative will benefit from input from CBIOE partnering institutions Carolinas Medical Center, the University of North Carolina at Chapel Hill and the University of North Carolina at Charlotte.

The CBIOE, located in Rhodes Engineering Research Building at Clemson University, is a state approved research and training center. Its mission is to promote the development of clinically relevant biomaterials technology and products for disease treatment and the transfer of this technology for patient care.

The NSF grant was among seven awarded to institutions to advance basic knowledge and control in the area of cellular and biomolecular engineering through the newly established NSF Emerging Frontiers in Research Innovation Office (EFRI). Other institutions recei
'/>"/>

Contact: Karen Burg
kburg@clemson.edu
864-656-6462
Clemson University
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Newly created cancer stem cells could aid breast cancer research
2. Linchpin gene may be useful target for new breast cancer therapies
3. Dietary calcium could possibly prevent the spread of breast cancer to bone
4. Researchers find new gene linked to breast cancer
5. Analysis of breast and colon cancer genes finds many areas of differences between tumors
6. Genome update defines landscape of breast and colon cancers
7. AACR, BCRF award inaugural grants in translational breast cancer research
8. Enhanced DNA-repair mechanism can cause breast cancer
9. Einstein researchers receive grants totaling $700,000 for innovative breast cancer research
10. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
11. A study by the MUHC and McGill University opens a new door to understanding cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...named 12 new grant recipients for 2009. The awards... across a broad spectrum of lupus research. All we...ential to drive scientific discovery to ultimately...ystemic lupus. , The 2009 grants go to both new ...n and include interdisciplinary and highly promisi...
(Date:11/24/2009)...lass of ring-shaped protein motors has been uncove...onal Laboratory (Berkeley Lab) using a state-of-th...nced Light Source (ALS). These protein motors play... and are vital to the survival of all biological c...man papillomavirus, which has been linked to cervi...
(Date:11/24/2009)...f debate. A high-profile study a few years ago sug...rbon from trees and leaves, evidence for a very cl...stems. , But new research from the University of...lgae provide a much richer diet for fish and other...s week in the Proceedings of the National Academy...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The National Center for Genome Resources Studies Childhood Diseases Using febits DNA Capture Method 13471 1The National Center for Genome Resources Studies Childhood Diseases Using febits DNA Capture Method 13471 2The National Center for Genome Resources Studies Childhood Diseases Using febits DNA Capture Method 13471 3Predictors of disease behavior change in Crohn 26 23146 3Bs disease 54046 1STAT3 gene regulates cancer stem cells in brain cancer 9525 1STAT3 gene regulates cancer stem cells in brain cancer 9525 2
...s, using data from the agency,s AURA satellite, de...er Antarctica this year is smaller than in previou... thickness of the ozone layer was the first based ...nt on the agency,s Aura spacecraft. Aura was launc...4 million square miles at its peak between Septemb...
... rate of life-threatening adverse reactions to the...responders to a bioterrorism incident, possibly at...d educational programs, according to a study in th...munization against smallpox in the United States c... in the article. Although the World Health Organiz...
...nd imaging technology, which can spot cracks in sp...sealed envelope and detect tumors without harmful ...the national meeting of the American Chemical Soci...perts Charles A. Schmuttenmaer , professor of ch...d director of the Center for Terahertz Research at...
Other Biology News:NASA's AURA satellite peers into Earth's ozone hole 2Serious adverse reactions to smallpox vaccine appear to be limited 2T-rays: New imaging technology spotlighted by American Chemical Society 2
(Date:11/24/2009)... Ambassador to also Visit Detroit , ... ,Who: David Appia, French Ambassador for Internat...st in France Agency, , , , ,What: Ambassador Appi...t pro-business initiatives adopted by France to fu...andscape for innovation and development., , ,When:...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Sigma-AldrichCorporat...nferenceonTuesday,December1stat1:45PMGMTinLondon,7...broadcastovertheInternetavailableat http://inve ...e"Webcast"icontoaccessthisfile. ,, AboutSigma...ghTechnologycompany.Itschemicalandbiochemicalprodu...
(Date:11/24/2009)...ov.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedth...approvedthe,investigationalnewdrugapplication(IND)...linformulationtotreatdiabetes.ThisIND,approvalallo..., Diabetesisadisordercharacteristicofhighbloodg...softenresultinseveremicro-and,macro-vasculardiseas...
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,N...company,today,announcedthatithassubmittedaMAAtothe...mpany,senzymereplacementtherapyindevelopment,forth...eting,applicationforvelaglucerasealfathathasbeensu...ndCanada. , Basedonaglobalsupplyshortageofthe...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...rican Academy of Ophthalmology,(AAO) 2008 Annual M...of,premium nutraceuticals for eye health, today an...y supplement to support the visual and overall,hea... -- 8% of the population and nearly 25% of those 6...n added to the 57 million,Americans with pre-diabe...
...Under Consideration, ROCKVILLE, Md., Nov. 10 Ent...rmaceutical company developing,therapeutics for th...oday,announced that it has met the primary endpoin... 1/2 study of MKC-1 in combination with pemetrexed...s., (Logo: http://www.newscom.com/cgi-bin/prnh/2...
...Xinhua-PRNewswire/ -- Simcere Pharmaceutical,Group...r of branded generic,pharmaceuticals and innovativ...ng China market, announced today its participation...mit 2008. The conference will be held at,the Manda...Simcere,s chief financial officer, Frank Zhigang Z...
Other Biology Technology:ScienceBased Health Announces the Launch of Diavis(TM), a New Dietary Supplement for the 81 Million Americans With or at Risk for Diabetes 2EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial 2EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial 3Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008 2
Chicken Anti-Human PFM8 Polyclonal Antibody, Unconjugated from ProSci, Inc
Rabbit Anti-NCoR2 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-PITPN Antibody, Unconjugated from Raybiotech, Inc.
Goat Anti-Human Nebraska Calf Diarrhea Virus Polyclonal Antibody, FITC Conjugated from Abcam
Biology Products: